Literature DB >> 17955302

The expression of type IV collagen alpha6 chain is related to the prognosis in patients with esophageal squamous cell carcinoma.

Yoshifumi Baba1, Ken-Ichi Iyama, Koei Ikeda, Shinji Ishikawa, Naoko Hayashi, Nobutomo Miyanari, Yoshikazu Sado, Yoshifumi Ninomiya, Hideo Baba.   

Abstract

BACKGROUND: The destruction of the basement membrane (BM) is the first step in cancer cell invasion and metastasis. Type IV collagen is a major component of the BM, and is composed of six genetically distinct alpha(IV) chains: alpha1(IV) to alpha6(IV). The loss of alpha5/alpha6(IV) chains from the epithelial BM at the early stage of cancer cell invasion has been reported in several cancers. However, the expression of alpha5/alpha6(IV) chains in esophageal squamous cell carcinoma (ESCC) remains unclear.
METHODS: The expression of alpha(IV) chains in 116 resected ESCC specimens was immunohistochemically examined. The role of alpha6(IV) chain was assessed in ESCC cell lines by short interfering RNA (siRNA).
RESULTS: In intraepithelial carcinoma, the alpha5/alpha6(IV) chains were stained in a continuous linear pattern in the BM. In some cases of ESCC with the invasion beyond the lamina propria, the alpha5/alpha6(IV) chains were lost in the BM zone surrounding the cancer cell nests, but in other cases they remained. In the former, the disease-free survival and overall survival were significantly better than in those with the latter. The down-regulation of alpha6(IV) chain expression by siRNA revealed a slight increase of cancer cell invasiveness.
CONCLUSIONS: The evaluation of alpha5/alpha6(IV) chains may be a useful marker for determining tumor cell properties, as a prognostic factor, in patients with ESCC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17955302     DOI: 10.1245/s10434-007-9592-4

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  8 in total

1.  Apparent diffusion coefficient correlation with oesophageal tumour stroma and angiogenesis.

Authors:  Tomoyoshi Aoyagi; Kiyohiko Shuto; Shinichi Okazumi; Kohichi Hayano; Asami Satoh; Hiroshige Saitoh; Hideaki Shimada; Yoshihiro Nabeya; Toshiki Kazama; Hisahiro Matsubara
Journal:  Eur Radiol       Date:  2012-01-19       Impact factor: 5.315

2.  Prognostic Value of Stromal Type IV Collagen Expression in Small Invasive Breast Cancers.

Authors:  Malin Jansson; Jessica Lindberg; Gunilla Rask; Johan Svensson; Ola Billing; Anoosheh Nazemroaya; Anette Berglund; Fredrik Wärnberg; Malin Sund
Journal:  Front Mol Biosci       Date:  2022-05-25

3.  Collagen mRNA levels changes during colorectal cancer carcinogenesis.

Authors:  Hanne Skovbjerg; Dorit Anthonsen; Inger M B Lothe; Kjell M Tveit; Elin H Kure; Lotte K Vogel
Journal:  BMC Cancer       Date:  2009-05-07       Impact factor: 4.430

Review 4.  Collagen as a double-edged sword in tumor progression.

Authors:  Min Fang; Jingping Yuan; Chunwei Peng; Yan Li
Journal:  Tumour Biol       Date:  2013-12-15

5.  Histological and molecular aspects of oral squamous cell carcinoma (Review).

Authors:  César Rivera; Bernardo Venegas
Journal:  Oncol Lett       Date:  2014-04-29       Impact factor: 2.967

6.  Gene expression identifies heterogeneity of metastatic behavior among high-grade non-translocation associated soft tissue sarcomas.

Authors:  Keith M Skubitz; Amy P N Skubitz; Wayne W Xu; Xianghua Luo; Pauline Lagarde; Jean-Michel Coindre; Frédéric Chibon
Journal:  J Transl Med       Date:  2014-06-20       Impact factor: 5.531

7.  Microarray expression profile analysis of mRNAs and long non-coding RNAs in pulmonary tuberculosis with different traditional Chinese medicine syndromes.

Authors:  Ting-Ting Jiang; Li-Liang Wei; Li-Ying Shi; Zhong-Liang Chen; Chong Wang; Chang-Ming Liu; Zhong-Jie Li; Ji-Cheng Li
Journal:  BMC Complement Altern Med       Date:  2016-11-17       Impact factor: 3.659

8.  The heterogenic tumor microenvironment of hepatocellular carcinoma and prognostic analysis based on tumor neo-vessels, macrophages and α-SMA.

Authors:  Min Fang; Jingping Yuan; Mengyuan Chen; Zongwen Sun; Lulu Liu; Guoping Cheng; Hangjie Ying; Shifeng Yang; Ming Chen
Journal:  Oncol Lett       Date:  2018-02-05       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.